Business Context and Reporting Period
This Form 8-K Current Report was filed by iSpecimen Inc. (ISPC) on December 21, 2023, covering events occurring on December 15, 2023, and December 20, 2023. The filing addresses corporate governance changes under Item 5.02 regarding the departure of a director and subsequent committee appointments.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition changes and contains no financial performance data.
Material Changes
- Director Resignation: Joseph J. Basile resigned from the Board of Directors, effective December 31, 2023. Consequently, he ceased serving on the audit committee and the nominating and corporate governance committee.
- Committee Appointments: To fill the vacancies created by Mr. Basile's resignation, the Board made the following appointments effective January 1, 2024:
- Theresa L. Mock was appointed to the audit committee.
- Steven Gullans was appointed to the nominating and corporate governance committee.
- Theresa L. Mock was appointed as chair of the nominating and corporate governance committee.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document confirms that Ms. Mock is considered an "independent director" under Nasdaq listing rules and Rule 10A-3.
Investor Verification Checklist
- Verify the effective date of Joseph J. Basile's resignation (December 31, 2023).
- Confirm the new composition of the audit committee and nominating and corporate governance committee effective January 1, 2024.
- Review the independence status of Theresa L. Mock as disclosed in the filing.
- Check for any subsequent filings regarding the appointment of a new director to replace Mr. Basile on the full Board, as this filing only addresses committee vacancies.